Why the study?
What is the prevalence of postirradiation angiosarcoma following breast-conserving therapy?
Population
Patients undergoing breast-conserving therapy
Comparison
Breast-conserving therapy (including irradiation) vs National database studies
Design
Other
Authors
Loading...
May indicate underestimation in national registries; leaves open whether this affects risk counseling or surveillance after breast-conserving therapy.
What is the prevalence of postirradiation angiosarcoma following breast-conserving therapy?
The prevalence of postirradiation angiosarcoma following breast-conserving therapy may be underestimated in current literature, which could impact management decisions in elderly patients.
West et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: